NO914724D0 - Somatotropiner med forandringer i alfa-spiral-1-omraadet ogkombinasjoner med andre mutasjoner - Google Patents

Somatotropiner med forandringer i alfa-spiral-1-omraadet ogkombinasjoner med andre mutasjoner

Info

Publication number
NO914724D0
NO914724D0 NO914724A NO914724A NO914724D0 NO 914724 D0 NO914724 D0 NO 914724D0 NO 914724 A NO914724 A NO 914724A NO 914724 A NO914724 A NO 914724A NO 914724 D0 NO914724 D0 NO 914724D0
Authority
NO
Norway
Prior art keywords
changes
mutations
helix
alpha
combinations
Prior art date
Application number
NO914724A
Other languages
English (en)
Other versions
NO301235B1 (no
NO914724L (no
Inventor
Meir Fischer
Michael Richard Lebens
Deborah Tardy Chaleff
Original Assignee
Bio Technology General Corp
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp, American Cyanamid Co filed Critical Bio Technology General Corp
Publication of NO914724D0 publication Critical patent/NO914724D0/no
Publication of NO914724L publication Critical patent/NO914724L/no
Publication of NO301235B1 publication Critical patent/NO301235B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Secondary Cells (AREA)
  • Mold Materials And Core Materials (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
NO914724A 1990-11-30 1991-11-29 Svinesomatotropiner med en dobbeltmutasjon i <alfa>-heliks-1-regionen NO301235B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62165690A 1990-11-30 1990-11-30

Publications (3)

Publication Number Publication Date
NO914724D0 true NO914724D0 (no) 1991-11-29
NO914724L NO914724L (no) 1992-06-01
NO301235B1 NO301235B1 (no) 1997-09-29

Family

ID=24491070

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914724A NO301235B1 (no) 1990-11-30 1991-11-29 Svinesomatotropiner med en dobbeltmutasjon i <alfa>-heliks-1-regionen

Country Status (20)

Country Link
US (1) US5548068A (no)
EP (1) EP0496973B1 (no)
JP (1) JPH05105634A (no)
KR (1) KR100193005B1 (no)
AT (1) ATE163045T1 (no)
CA (1) CA2056467C (no)
DE (1) DE69128877T2 (no)
DK (1) DK0496973T3 (no)
ES (1) ES2112847T3 (no)
FI (1) FI104489B (no)
GR (1) GR3026761T3 (no)
HU (1) HU215947B (no)
IE (1) IE914153A1 (no)
IL (1) IL100169A0 (no)
NO (1) NO301235B1 (no)
NZ (2) NZ260103A (no)
PT (1) PT99648B (no)
SG (1) SG49702A1 (no)
TW (1) TW198040B (no)
ZA (1) ZA919453B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006079A (en) * 1997-06-13 1999-12-21 Motorola, Inc. Radio having a fast adapting direct conversion receiver
TR200504220T2 (tr) 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
KR20090083958A (ko) 2006-10-20 2009-08-04 바이오겐 아이덱 엠에이 인코포레이티드 가용성 림프독소-베타-수용체를 이용한 탈수초성 장애의 치료
WO2012116203A1 (en) 2011-02-23 2012-08-30 Massachusetts Institute Of Technology Water soluble membrane proteins and methods for the preparation and use thereof
US10373702B2 (en) 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE198353T1 (de) * 1988-08-24 2001-01-15 American Cyanamid Co Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung
CA2001774C (en) * 1988-10-28 2001-10-16 James A. Wells Method for identifying active domains and amino acid residues in polypeptides and hormone variants

Also Published As

Publication number Publication date
JPH05105634A (ja) 1993-04-27
HU215947B (hu) 1999-03-29
PT99648B (pt) 1999-05-31
FI915654A (fi) 1992-05-31
FI915654A0 (fi) 1991-11-29
NO301235B1 (no) 1997-09-29
KR920009413A (ko) 1992-06-25
EP0496973A3 (en) 1993-02-24
DE69128877D1 (de) 1998-03-12
IL100169A0 (en) 1992-08-18
CA2056467C (en) 1998-07-07
EP0496973A2 (en) 1992-08-05
DE69128877T2 (de) 1998-06-18
ES2112847T3 (es) 1998-04-16
HU913723D0 (en) 1992-02-28
DK0496973T3 (da) 1998-05-04
CA2056467A1 (en) 1992-05-31
EP0496973B1 (en) 1998-02-04
AU8830091A (en) 1992-06-04
GR3026761T3 (en) 1998-07-31
ATE163045T1 (de) 1998-02-15
US5548068A (en) 1996-08-20
AU662493B2 (en) 1995-09-07
NO914724L (no) 1992-06-01
FI104489B (fi) 2000-02-15
HUT62327A (en) 1993-04-28
ZA919453B (en) 1992-08-26
NZ260103A (en) 1996-10-28
NZ240718A (en) 1996-10-28
KR100193005B1 (ko) 1999-06-15
TW198040B (no) 1993-01-11
PT99648A (pt) 1992-10-30
SG49702A1 (en) 1998-06-15
IE914153A1 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
PL274485A1 (en) Method of obtaining stable preparations of human proteins
DK105892A (da) Dna-sekvens, der koder for et modificeret human-beta-interferonprotein (ifn-beta), hvori 17-cysteinresten er udeladt eller udskiftet med en anden aminosyrerest, ekspressionsvektor indeholdende dna-sekvensen, vaertcelle eller -organisme transformeret med ekspressionsvektoren samt fremgangsmaade til fremstilling af det modificerede protein.
EP0210189A4 (en) RECOMBINANT ALVEOLAR SURFACE ACTIVE PROTEIN.
DE3650751T2 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
NO914724D0 (no) Somatotropiner med forandringer i alfa-spiral-1-omraadet ogkombinasjoner med andre mutasjoner
NO914720L (no) Somatotropiner med forandringer i alfa-spiral-3-omraadet, alfa-spiral-2-omraadekombinasjoner derav og i kombinasjon medandre mutasjoner
DE3850654D1 (de) Immunglobulin-e-kompetitor.
GR3031927T3 (en) Cysteine depleted il-6 muteins
EP0315118A3 (en) Dna coding for endothelin and use thereof
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003